CDk4/6 - Globe Thesis - Globe Thesis

Keyword [CDk4/6] Result: 21 - 40 \| Page: 2 of 2
21.	Genetic and pharmacologic regulation of cyclin dependent kinase 4 and 6 activity in mammalian hematopoiesis
22.	Delivery and efficacy of CDK4/6 inhibitors in the treatment of brain tumors
23.	Preclinical characterization of a CDK4/6/ARK5 inhibitor: on 12330
24.	Genomic Alterations in Bladder Cancer Modulate Response to Therap
25.	Study On Protective Effect Of CDK4/6 Inhibitor Palbociclib In Diabetic Cardiomyopathy And Their Mechanisms
26.	Investigation On Anti-tumor Activity Of CDK4/6 Inhibitor In Non-small Cell Lung Cancer Cell Lines And The Mechanism Of Overcoming The Third Generation EGFR-TKI Acquired Resistance
27.	1.A CRISPR Knockout Negative Screen Reveals Synergy Between CDKs Inhibitor And Metformin In The Treatment Of Human Cancer 2.Methylation Silencing Of TGF-? Receptor Type ? Is Involved In Malignant Transformation Of Esophageal Squamous Cell Carcinoma
28.	The Adaptive Reaction And Drug Resistance To CDK4/6 Inhibior LY2835219 In Breast Cancer
29.	CDK4/6 Inhibitor Palbociclib Enhances The Sensitivity Of RB-Proficient Triple-Negative Breast Cancer To Cisplatin
30.	The Anti-tumor Effect And Mechanism Of CDK4/6 Inhibitor Palbociclib In Small Cell Lungcancer Cell Lins
31.	The Role Of Osimertinib Combined With PD0332991 In EGFR-TKIs Resistant Lung Cancer Cells
32.	The Treatment Of KRAS Mutant Gastric Cancer And Its Mechanism By Dual-target Combination Therapy
33.	A Meta-Analysis Of Cyclin-Dependent Kinase 4/6 Inhibitors In Postmenopausal Patients With Hormone Receptor Positive,HER2-Negative Advanced Breast Cancer
34.	Fulvestrant Plus CDK4/6 Inhibitors Or PI3K/mTOR/AKT Inhibitors For HR+/HER2-advanced Breast Cancer That Failed In The First-line Endocrine Therapy:A Meta-analysis
35.	Efficacy And Safety Of CDK4/6 Inhibitors In Hormone Receptor Positive And HER2-negative Advanced Breast Cancer: A Meta-analysis
36.	The Efficacy And Safety Of Combination CDK4/6 Inhibitors And Endocrine Therapy For Advanced Breast Cancer:A Meta-analysis
37.	Treatment Of Palbociclib In Hormone Receptor Positive Breast Cancer: A Real-world Study And Efficacy Prediction Model
38.	CDK4/6 Inhibitor,abemaciclib Affects The Malignant Biological Behaviors Of Nasopharyngeal Carcinoma Cells
39.	The Effect And Mechanism Of Aminoquinol,a Novel CDK4/6 Inhibitor,in The Treatment Of Prostate Cancer
40.	Vortioxetine Inhibits The Proliferation Of Esophageal Squamous Cell Carcinoma(ESCC) By Downregulating CDK4/6-RB1 Signaling Pathway
<<First <Prev Next> Last>> Jump to